Multiple Myeloma CAR-T Management - Partners in Practice
22 Oct 2026
25m
Oncology Brothers · Health
Oncology Brothers: Practice-Changing Cancer Discussions
The Oncology Brothers Podcast, led by Drs. Rahul and Rohit Gosain, is dedicated to bridging the gap between academic cancer centers and community oncology in the ever-evolving field of hematology & oncology. With a mission to disseminate crucial information to the medical community, this oncology podcast is not for medical advice but rather serves as a beacon for physicians, nurses, trainees, and advanced practice providers (APPs) involved in the care of cancer patients. Drs. Rahul and Rohit Gosain, both esteemed oncologists, bring a wealth of experience and expertise from their general community practice to these discussions. Through short and engaging interviews with world-renowned researchers, clinicians, hematologists, and oncologists, they present practice-changing data in a concise, bite-sized format. Get the latest FDA approvals news, oncology conference highlights, and treatment algorithms in 25 minutes or less. Conversations center around common cancers you see in your clinic like breast cancer, prostate cancer, kidney cancer, bladder cancer, lung cancer, and GI cancers. With new indications and approvals, we talk about how to incorporate this data in your day to day clinical practice. Each episode includes visual presentations so you can follow along within the podcast players and on YouTube @oncbrothers. These visual tools and algorithms will provide an outline on what is covered in each episode. Immediately apply the latest insights and advancements in your daily practice, ensuring the delivery of optimal cancer care to patients within your local communities. If you want to navigate the complexities of your hematology & oncology practice and stay current, the Oncology Brothers Podcast offers invaluable insights and practical takeaways to enhance your professional journey and improve patient outcomes. For more information, please visit: www.oncbrothers.com, and connect with us on Twitter/X/Instagram/TikTok: @oncbrothers, or email us at [email protected] Privacy Policy: https://oncbrothers.com/privacy-policy Terms & Conditions: https://oncbrothers.com/terms-and-conditions
Episodes
CAR-T Cell Therapy in Multiple Myeloma & Lymphoma - Clinical Foundations
19 Oct 2026
22m
Rapid Fire Rounds - Thrombocytopenia Workup & Management with Dr. Ronak Mistry
12 Oct 2026
27m
Challenging Cases in Small Cell Lung Cancer (SCLC) - Drs. Estela Rodriguez & Misty Shields
08 Oct 2026
18m
WCLC 2026 Highlights: MAVERICK, ADAURA, HARMONi, PAPILLON, DESTINY-Lung04 with Dr. Christine Lovly
05 Oct 2026
19m
AI processedWorld Lung 2026 clinical data establishes new standards for lung cancer management, emphasizing precision and toxicity reduction. Dr. Christine Lovly, a thoracic medical oncologist from City of Hope, highlights the MAVERICK trial’s shift toward MRI surveillance for small cell lung cancer, effectively replacing prophyla...
Managing Toxicities of HER2+ Therapies in Upper GI Cancer - Trastuzumab, T-DXd, Zanidatamab
30 Sep 2026
21m
Upper GI Treatment Algorithm (Esophageal, Gastric, GEJ) - Dr. Sam Klempner
28 Sep 2026
26m
AI processedTreatment algorithms for upper GI cancers, including esophageal, GE-junction, and gastric adenocarcinoma, have shifted toward intensive systemic therapy and biomarker-directed approaches. For resectable disease, the standard of care involves peri-operative durvalumab combined with FLOT chemotherapy, followed by surgery...
Follicular & Mantle Cell Lymphoma Treatment Algorithm: Dr. Jonathan Friedberg
24 Sep 2026
22m
AI processedTreatment algorithms for follicular and mantle cell lymphoma prioritize clinical outcomes and toxicity management. For follicular lymphoma, bone marrow biopsies are largely unnecessary, and rituximab maintenance is increasingly omitted due to infection risks and lack of overall survival benefits. In relapsed settings, ...
Diffuse Large B-cell Lymphoma (DLBCL) Treatment Algorithm: Dr. Mazyar Shadman
22 Sep 2026
21m
AI processedDiffuse Large B-cell Lymphoma (DLBCL) treatment requires a strategic approach balancing frontline regimens with emerging therapies for relapsed or refractory disease. Frontline management centers on R-CHOP or Pola-R-CHOP, with the latter increasingly favored for patients with an IPI score of two or higher. For primary ...
Revolution Medicines CEO Dr. Mark Goldsmith: Daraxonrasib dream to reality
21 Sep 2026
26m
Camizestrant + CDK 46i FDA Approval in Hormone Receptor Positive Breast Cancer SERENA-6
16 Sep 2026
20m
SURPASS-ET: FDA Approval of Ropeginterferon alfa-2b in Essential Thrombocythemia (ET)
14 Sep 2026
22m
Myelofibrosis Treatment Algorithm Discussion: Dr. Nico Gagelmann
07 Sep 2026
24m
Managing Toxicities of Therapies in Polycythemia Vera (PV) / Essential Thrombocythemia (ET)
04 Sep 2026
26m
VERIFY: FDA Approval of Rusfertide in Polycythemia Vera (PV) - Dr. Andrew Kuykendall
02 Sep 2026
19m
Polycythemia vera (PV) and Essential thrombocythemia (ET) Treatment Algorithm: Dr. Aaron Gerds
31 Aug 2026
28m
Multiple Myeloma Management - Partners in Practice with Dr. Ajai Chari Team from UCSF
27 Aug 2026
21m
HERIZON-GEA-01: FDA Approval of Zanidatamab + Tislelizumab for HER2+ Esophageai/GEJ/Gastric Adeno
25 Aug 2026
16m
Rapid Fire Rounds - Multiple Myeloma Management with Dr. Joseph Mikhael
24 Aug 2026
25m
EXCALIBER-RRMM - Iberdomide/Dara/Dex FDA Approval for R/R Multiple Myeloma: Dr. Sagar Lonial
20 Aug 2026
20m
Follow this podcast in Podwise
Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.